**参与“植入式医疗器械”国家研发项目**  

MST(KOREA) CO., LTD.（MST·董事长：文雄植·[www.BioCleanAct.com](http://www.BioCleanAct.com)·品牌名：BioCleanAct™）中央研究所被选为**区域特色产业培育+（R&D）区域明星企业培育项目**，并已执行**为期两年的国家研发项目（2023–2024）。**  

**[开发基于天然合成TPU抗菌复合材料的5Fr、325psi高耐压型防止血流感染的外周置入中心静脉导管（PICC）]**  

MST成功完成并推进了**应用天然抗菌复合材料的无感染植入式PICC产品商业化的国家研发项目。**  

此外，MST的**新型天然抗菌材料**（用于防止细菌二次感染）已与以下公司在医疗设备领域开展联合研发合作：  

- 日本库拉雷集团医疗本部  

- 德国西门子医疗  

- 韩国三星电子医疗事业部  

- 世运医疗（Sewoon Medical）等

**Participation in the National R&D Project for "Implantable Medical Devices"**  

MST(KOREA) CO., LTD. (MST, Chairman: Woongsig Moon, [www.BioCleanAct.com](http://www.BioCleanAct.com), Brand: BioCleanAct™) Central Research Institute was selected for the **Regional Specialized Industry Promotion + (R&D) Regional Star Enterprise Promotion Project** and has been conducting a **national research and development project for two years (2023–2024).**  

**[Development of a high-pressure 5Fr, 325psi peripherally inserted central catheter (PICC) for the prevention of bloodstream infections using a natural compound-based TPU antibacterial compound]**  

MST successfully carried out and completed a **national R&D commercialization project** for an **Infection-free implantable PICC** incorporating its **natural compound-based antibacterial material.**  

Furthermore, MST's **new natural antibacterial material** (for secondary bacterial infection prevention) has been the subject of joint research and development in the medical device sector with:  

- Kuraray Group Medical Division (Japan)  

- Siemens Healthineers (Germany)  

- Samsung Electronics Medical Division  

- Sewoon Medical, and others.